VASAMED, Inc.
VSMD
$0.00
$0.000.00%
| 06/30/2009 | 03/31/2009 | ||||
|---|---|---|---|---|---|
| Revenue | -28.77% | 0.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -28.77% | 0.82% | |||
| Cost of Revenue | -9.69% | 44.44% | |||
| Gross Profit | -43.05% | -17.77% | |||
| SG&A Expenses | -3.99% | -9.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.34% | 7.65% | |||
| Operating Income | -36.21% | -34.66% | |||
| Income Before Tax | -27.55% | -23.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.55% | -23.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.55% | -23.79% | |||
| EBIT | -36.21% | -34.66% | |||
| EBITDA | -44.54% | -44.50% | |||
| EPS Basic | -27.73% | -23.67% | |||
| Normalized Basic EPS | -27.81% | -23.55% | |||
| EPS Diluted | -27.73% | -23.67% | |||
| Normalized Diluted EPS | -27.81% | -23.55% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
